Presentation Information
[1P-90]Development of bispecific antibodies to reduce side effects and induce tumor-specific activation
Yuki KATO1, *Takeru KANAZU1, Izumi KUMAGAI1, Ryutaro ASANO1 (1. Department of Biotechnology and Life Science, Graduate School of Engineering, Tokyo University of Agriculture and Technology)
Keywords:
Bispecific antibody,T cell co-stimulation,Single chain antibody,EGFR,MMP